Virus was produced from plasmid-based DNA segments of a common Wuhan strain. The S-gene was site-specifically replaced with a cloned BA.5-based S-gene sequence.
Virus has been produced from plasmid-based DNA segments of a common Wuhan strain. The S-gene was site-specifically replaced with a cloned BA.2-based S-gene sequence.
Virus was produced from plasmid-based DNA segments of a common Wuhan strain. The S-gene was site-specifically replaced with a cloned BA.1-based S-gene sequence.
plasmid encoding the VSV antigenome, lacking the G gene, and encoding mCherry, for producing recombinant VSV lacking a glycoprotein for pseudotyping assays or for cloning and production of VSV encoding foreign glycoproteins.
plasmid encoding the VSV antigenome, lacking the G gene, and encoding eGFP, for producing recombinant VSV lacking a glycoprotein for pseudotyping assays or for cloning and production of VSV encoding foreign glycoproteins.
Infectious supernatant containing LCMV strain Clone 13 with a point mutation at glycoprotein Aa38 (phenylalanine to leucine), resulting in a loss of binding of the otherwise immunodominant and here mutated H-2Db-presente
Infectious supernatant containing LCMV strain Clone 13 with a point mutation at glycoprotein Aa280 (asparagine to aspartic acid), resulting in a loss of binding of the otherwise immunodominant and here mutated H-2Db-pres
Infectious supernatant containing LCMV strain Clone 13 with a point mutation at nucleoprotein Aa400 (asparagine to serine), resulting in a loss of binding of the otherwise immunodominant and here mutated H-2Db-presented
Plasmid contains the entire genome of HIV-1 (NL4-3) with the respective specific mutations in the protease gene. These may confer drug resistance to specific HIV protease inhibitors and have been identified in clinical specimens from individuals with therapeutic failure.